Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin
about
Molecular basis of physiological heart growth: fundamental concepts and new playersmTOR signaling in tumorigenesisUterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling.Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulationAssociation of aminoacyl-tRNA synthetases gene polymorphisms with the risk of congenital heart disease in the Chinese Han populationStromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.Specific disruption of Tsc1 in ovarian granulosa cells promotes ovulation and causes progressive accumulation of corpora luteaCardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group.Lymphangioleiomyomatosis - a wolf in sheep's clothing.Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repressionAdipocyte-specific loss of PPARγ attenuates cardiac hypertrophy.Loss of neurotrophin-3 from smooth muscle disrupts vagal gastrointestinal afferent signaling and satiation.Mammalian target of rapamycin signaling in cardiac physiology and disease.The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3.The Src homology and collagen A (ShcA) adaptor protein is required for the spatial organization of the costamere/Z-disk network during heart development.Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload.Glucocorticoid receptor is required for foetal heart maturation.Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization.Conditionally targeted deletion of PSEN1 leads to diastolic heart dysfunction.Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.mTOR promotes pituitary tumor development through activation of PTTG1.Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.
P2860
Q27006868-4EEC1236-5E30-4818-80E9-6FD967F8A2D1Q28252695-4BA4072D-0E27-4348-B698-F4F75493FCE5Q30411083-543C1238-3906-42C8-89A3-C2DC3751A1FDQ31116089-B6831DB7-A38F-49CC-AA07-70CB17ECD55EQ33986353-DAE38128-7FDB-45F0-9454-61712CAC663CQ34307302-EED6A30B-977C-4C17-90F6-B7B51E738D02Q34332167-E5183093-A441-4526-891B-5BF35F9CC2BAQ34390606-EACDDB49-3971-4BB8-97B1-9F9C154DC1D9Q34555807-916424A3-E013-4FD9-978B-91C7EADC296EQ35115152-C2DCA198-E992-4DBF-B190-3C0C94864A3AQ36357766-8AEC32E2-0F37-4AD3-83DA-A88F7B3DB4FFQ36710861-8068562F-F912-4391-B20B-39D6CF2CC27BQ36812158-ABCA24DE-A810-4463-A854-C11A323AEEF1Q37316215-445CB186-AFD0-4212-8AC1-22D4F1BD2D22Q37440620-7C32AF3E-0464-4361-BE37-0D269E1D4844Q37715817-B9284917-7A59-47EE-99C9-8FC3C9C5B08CQ38941373-7EDCEE7D-0077-4FF9-9F31-F0E97B952548Q39256900-7C38C717-0B2E-44CC-8A58-66FA3F1893F8Q40984224-AD9F22B3-FA9D-4037-87F5-215165D39CF1Q41863155-FE15B0A5-32D0-45AE-9C34-2D55093908C4Q43168046-31F1B1CE-45E2-4344-9D07-79C76401614BQ44440207-7E6CECC8-CA8F-4CA6-BC23-6D0B5BFC00CCQ46117088-962ED562-329D-4C05-9519-17AB60C6E8D0Q48272508-F0642F33-4B64-42E9-BD27-48770E3C1EC0Q51006793-7F2AE8A9-AB36-4C32-8086-2CF6486E1176Q51571729-A590E8D3-8261-470E-B5DF-38EE36092B57Q55026570-FC706E56-FB7C-4BA2-8EE1-15DD31887FAB
P2860
Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@ast
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@en
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@nl
type
label
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@ast
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@en
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@nl
prefLabel
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@ast
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@en
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@nl
P2093
P2860
P356
P1476
Smooth muscle protein-22-media ...... ated and reversed by rapamycin
@en
P2093
Amy J Malhowski
Blanton Robert
David J Kwiatkowski
Geraldine A Finlay
Haider Hira
Rod Warburton
Sarah Bashiruddin
P2860
P304
P356
10.1093/HMG/DDQ570
P577
2011-01-06T00:00:00Z